Kyle P Eagen

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Transcription Factor

Circulating Tumor

Top Venues

Cancer research

The EMBO journal

Nature genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Yeying Huang, R Taylor Durall, Nhi M Luong, Hans J Hertzler, Julianna Huang, Prafulla C Gokhale, Brittaney A Leeper, Nicole S Persky, David E Root, Praju Vikas Anekal, Paula Montero Llopis, Clement N David, Jeffery L Kutok, Alejandra Raimondi, Karan Saluja, Jia Luo, Cynthia A Zahnow, Biniam Adane, Kimberly Stegmaier, Catherine E Hawkins, Christopher Ponne, Quan Le, Geoffrey I Shapiro, Madeleine E Lemieux, Kyle P Eagen, Christopher A French
EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes. Cancer research (2023)
R Taylor Durall, Julianna Huang, Luke Wojenski, Yeying Huang, Prafulla C Gokhale, Brittaney A Leeper, Joshua O Nash, Pedro L Ballester, Scott Davidson, Adam Shlien, Emmanuel Sotirakis, Fabien Bertaux, Vincent Dubus, Jia Luo, Catherine J Wu, Derin B Keskin, Kyle P Eagen, Geoffrey I Shapiro, Christopher A French
The BRD4-NUT fusion alone drives malignant transformation of NUT carcinoma. Cancer research (2023)
Kyle P Eagen
BET proteins loop and compartmentalize the 3D genome. Nature genetics 54 (4) (2022)
Ann K Hogan, Kizhakke Mattada Sathyan, Alexander B Willis, Sakshi Khurana, Shashank Srivastava, Ewelina Zasadzińska, Alexander S Lee, Aaron O Bailey, Matthew N Gaynes, Jiehuan Huang, Justin Bodner, Celeste D Rosencrance, Kelvin A Wong, Marc A Morgan, Kyle P Eagen, Ali Shilatifard, Daniel R Foltz
UBR7 acts as a histone chaperone for post-nucleosomal histone H3. The EMBO journal (2021)
Kyle P Eagen, Christopher A French
Supercharging BRD4 with NUT in carcinoma. Oncogene 40 (8) (2021)